How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Phototherapy Equipments Market
- By Product Type: UVB Phototherapy Devices, PUVA Phototherapy Devices, Blue Light Therapy Devices, Red Light Therapy Devices, Infrared Phototherapy Devices
- By Application: Psoriasis Treatment, Atopic Dermatitis Treatment, Neonatal Jaundice Treatment, Vitiligo Treatment, Seasonal Affective Disorder (SAD) Treatment
- By End User: Hospitals, Dermatology Clinics, Home Care Settings, Specialty Clinics, Phototherapy Centers
- By Light Source: LED-based Phototherapy Devices, Fluorescent Lamp-based Devices, Laser-based Phototherapy Devices, Halogen Lamp-based Devices
- By Mode of Operation: Stationary Phototherapy Units, Portable Phototherapy Devices, Handheld Phototherapy Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - UVB Phototherapy Devices leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Phototherapy Equipments Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Application 5
End User 5
Light Source 4
Mode of Operation 3
Companies profiled
Philips Healthcare
GE Healthcare
Natus Medical Incorporated
Drägerwerk AG & Co. KGaA
Welch Allyn (Hill-Rom)
Bilirubin Lights Inc.
Atom Medical Corporation
Heilind Electronics
Phoenix Medical Systems
Lullaby Phototherapy
MediLED
Natus Medical
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Natus Medical Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Drägerwerk AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Welch Allyn (Hill-Rom)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Bilirubin Lights Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Atom Medical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Heilind Electronics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Phoenix Medical Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Lullaby Phototherapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MediLED
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Natus Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Medela AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioPharma Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Korea Meditech
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$971.5M by 2033 · 8.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- UVB Phototherapy Devices56.8
- PUVA Phototherapy Devices10.2
- Blue Light Therapy Devices12.1
- Red Light Therapy Devices13.1
- Infrared Phototherapy Devices7.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$164.9M → $300.0M · 7.8%
Europe$115.0M → $202.7M · 7.3%
Asia Pacific$105.0M → $227.9M · 10.2%
Latin America$65.0M → $125.9M · 8.6%
Middle East and Africa$50.0M → $98.0M · 8.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.612026
8.622027
8.642028
8.642029
8.672030
8.682031
8.692032
8.692033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Healthcare15.8
- GE Healthcare21.5
- Natus Medical Incorporated9.1
- Drägerwerk AG & Co. KGaA5.2
- Welch Allyn (Hill-Rom)9.7
- Bilirubin Lights Inc.10.8
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type14.6%
Application12.6%
End User28.8%
Light Source17.7%
Mode of Operation26.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.4
- Europe21.2
- Asia Pacific23.9
- Latin America13.2
- Middle East and Africa10.3
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Healthcare | 83 | 84 | 91 | 94 | 76 | 77 | 84 |
| GE Healthcare | 79 | 84 | 89 | 78 | 84 | 87 | 84 |
| Natus Medical Incorporated | 80 | 77 | 79 | 64 | 64 | 74 | 73 |
| Drägerwerk AG & Co. KGaA | 58 | 69 | 66 | 71 | 78 | 62 | 67 |
| Welch Allyn (Hill-Rom) | 55 | 73 | 56 | 76 | 56 | 59 | 63 |
| Bilirubin Lights Inc. | 46 | 54 | 69 | 51 | 46 | 47 | 52 |
| Atom Medical Corporation | 50 | 60 | 46 | 56 | 58 | 57 | 55 |
| Heilind Electronics | 42 | 43 | 46 | 40 | 37 | 36 | 41 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Healthcare
- GE Healthcare
- Natus Medical Incorporated
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Healthcare | ✓ | ◐ | ✓ | ✓ | ✓ | ◐ |
| GE Healthcare | ◐ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Natus Medical Incorporated | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Drägerwerk AG & Co. KGaA | − | ✓ | − | ✓ | ◐ | ✓ |
| Welch Allyn (Hill-Rom) | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Bilirubin Lights Inc. | − | − | ◐ | − | ◐ | − |
| Atom Medical Corporation | − | ◐ | − | − | − | − |
| Heilind Electronics | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Healthcare84
2GE Healthcare84
3Natus Medical Incorporated73
4Drägerwerk AG & Co. KGaA67
5Welch Allyn (Hill-Rom)63
6Atom Medical Corporation55
7Bilirubin Lights Inc.52
8Heilind Electronics41
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips HealthcareGE Healthcare
Challenger2
Strong scale, closing on the leaders.
Natus Medical IncorporatedDrägerwerk AG & Co. KGaA
Contender1
Focused players with pockets of strength.
Welch Allyn (Hill-Rom)
Niche3
Specialists in a single segment or region.
Bilirubin Lights Inc.Atom Medical CorporationHeilind Electronics
Go-to-market strategy
Land Product Type in North America, then scale across Phototherapy Equipments Market — a $462M beachhead inside a $7.92B market.
Beachhead (SOM)$462Mobtainable near-term
Serviceable (SAM)$2.72Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
UVB Phototherapy Devices
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
PUVA Phototherapy Devices
Strong fit — clear ROI and a fast path to value.
End user64 fit
Blue Light Therapy Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel28%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Phototherapy Equipments Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified20%
Evaluation14%
Closed-won6%
$11.1KCAC
$40KLTV
3.6:1LTV : CAC
< 5 moCAC payback
Investment thesis
Phototherapy Equipments Market is a durable-growth opportunity — $1.43B by 2033, compounding at 9.2%.
TAM · 2025$703Mtoday
TAM · 2033$1.43Bforecast
CAGR9.2%2027–2033
Cumulative$9.25Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.43BTotal addressable market
SAM$524MServiceable available market
SOM$115MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.43BLarge & growingTAM by 2033 at 9.2% CAGR
$524MServiceable nowreachable with today’s model
$115MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.11BBear6.0% CAGR
$1.43BBase9.2% CAGR
$1.83BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Phototherapy Equipments Market — a $9.59B market by 2033. Plan: grow share from 7.8% to 14.0%.
Market size · 2033$9.59Btotal addressable
Market CAGR11.2%2027–2033
Target share14.0%from 7.8% today
Revenue ambition$1.34Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.8% | 14.0% | At risk |
| Revenue | $766M | $1.34B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 29.2% | 38.2% | On track |
| Customer retention | 86.6% | 95.3% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $167M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Phototherapy Equipments Market conversation — a $5.42B market you can size, segment and defend in minutes.
Market size · 2033$5.42Btotal opportunity
Growth7.9%CAGR to 2033
Addressable buyers1,029+accounts in scope
Typical ROI5.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.1×return on cost, year one
< 3 mopayback period
$61K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Philips HealthcareGE HealthcareNatus Medical IncorporatedDrägerwerk AG & Co. KGaAWelch Allyn (Hill-Rom)Bilirubin Lights Inc.Atom Medical CorporationHeilind Electronics+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Phototherapy Equipments Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Phototherapy Equipments Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Pneumococcal Vaccines Market
Market size, share, segmentation and regional forecast.
$5.7B by 2033 · 9.14% CAGR
View reportOrthodontic Equipments Market
Market size, share, segmentation and regional forecast.
$8.1B by 2033 · 6.02% CAGR
View reportOrthopedic Trauma Device Market
Market size, share, segmentation and regional forecast.
$8.9B by 2031 · 3.27% CAGR
View reportOsteosynthesis External Fixation Devices Market
Market size, share, segmentation and regional forecast.
$4.1B by 2031 · 9.80% CAGR
View reportTreatment Patient Simulators Market
Market size, share, segmentation and regional forecast.
$5.8B by 2031 · 8.37% CAGR
View reportTangential Flow Filtration Device Market
Market size, share, segmentation and regional forecast.
$11.0B by 2031 · 9.61% CAGR
View reportTransfusion Diagnostic Equipments Market
Market size, share, segmentation and regional forecast.
$3.7B by 2033 · 5.77% CAGR
View reportPulmonary Arterial Hypertension Drugs Market
Market size, share, segmentation and regional forecast.
$3.6B by 2032 · 8.55% CAGR
View reportPulmonary Drugs Market
Market size, share, segmentation and regional forecast.
$3.0B by 2033 · 8.71% CAGR
View reportNuclear Medicine Equipments Market
Market size, share, segmentation and regional forecast.
$12.6B by 2032 · 10.35% CAGR
View reportLiposome Drug Delivery Market
Market size, share, segmentation and regional forecast.
$7.1B by 2033 · 4.36% CAGR
View reportObstructive Sleep Apnea Therapeutic Device Market
Market size, share, segmentation and regional forecast.
$2.0B by 2031 · 10.63% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.